Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

Rhea-AI Summary

Cannara Biotech (TSXV: LOVE) (OTCQB: LOVFF) has announced an upcoming investor webcast scheduled for Thursday, December 19th, 2024, at 2:00 PM ET. The company, a vertically integrated cannabis producer operating two mega facilities in Quebec with over 1,650,000 sq. ft. of space, will feature CFO Nicholas Sosiak presenting key financial and operational results for the fiscal year ended August 31, 2024.

The presentation will be followed by an interactive Q&A session where investors can engage directly with management. Pre-registration is required through the provided Zoom webinar link, and an archived version of the webcast and presentation will be available on Cannara's investor relations website.

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, December 19^th, 2024, at 2:00 PM ET.

During the webcast, Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operational results for the fiscal year ended August 31, 2024. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A session.

Date & Time: December 19, 2024, at 2:00 PM ET
Webcast Link: https://us02web.zoom.us/webinar/register/WN_QVPjGIwzSvKgaiRBHLBfrQ

To listen to the webcast or participate in the live Q&A, please pre-register using the link provided above. An archived version of the webcast and presentation will be available on the Company's website, https://investors.cannara.ca/

ABOUT CANNARA

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.

CONTACT

Nicholas Sosiak, CPA, CA Chief Financial Officer nick@cannara.ca

Zohar Krivorot  President & Chief Executive Officer  zohar@cannara.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FAQ

When is Cannara Biotech (LOVFF) hosting its investor webcast for FY2024 results?

Cannara Biotech is hosting its investor webcast on Thursday, December 19th, 2024, at 2:00 PM ET.

What will be covered in Cannara Biotech's (LOVFF) December 2024 investor presentation?

The presentation will cover key financial and operational results for Cannara Biotech's fiscal year ended August 31, 2024, presented by CFO Nicholas Sosiak.

How can investors participate in Cannara Biotech's (LOVFF) December 2024 webcast?

Investors need to pre-register through the provided Zoom webinar link to participate in the live webcast and Q&A session.

What is the total facility space of Cannara Biotech's (LOVFF) Quebec operations?

Cannara Biotech operates two mega facilities in Quebec spanning over 1,650,000 sq. ft.

Where can investors find the archived version of Cannara Biotech's (LOVFF) December 2024 presentation?

The archived version of the webcast and presentation will be available on Cannara's investor relations website at investors.cannara.ca.